Antibiotic inhibition and binding studies with a group A streptococcal L-form.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001414:Bacitracin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D007740:L Forms / Q000187:drug effects; D009675:Novobiocin / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D012310:Ristocetin / Q000494:pharmacology; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000254:growth & development*; D014316:Tritium; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D011113:Polymyxins; D014316:Tritium; D012310:Ristocetin; D001414:Bacitracin; D009675:Novobiocin; D003609:Dactinomycin; D011691:Puromycin; D002701:Chloramphenicol; D014640:Vancomycin; D003523:Cycloserine; D010400:Penicillin G